Online presentations from this meeting are subject to copyright protection. Permission from the speaker is required prior to any copying, reproducing, or rebroadcasting any portion of the speaker's presentations. Additional copyright and legal policies of The National Academies can be read in the National Academies Legal Statement.

Wednesday, October 1, 2003

8:30        
Continental Breakfast

9:00        
Opening Remarks / Summary of Day 1
Stanley Lemon, M.D., Vice Chair, Forum on Emerging Infections

LEARNING FROM OUR LESSONS: THE AGENDA AHEAD

Session IV:  The Research Agenda and Emerging Technologies
Moderator:
Carole Heilman Ph.D., Director, Division of Microbiology and Infectious Diseases, NIAID, NIH

9:15-9:40
Coronavirus Research
Mark Denison, M.D., Vanderbilt University
View Slides  

9:40-10:00
Discussion

10:00-10:25
TIGER Technology for Emerging Infectious Disease Surveillance
Ranga Sampath, Ibis Therapeutics, A Division of Isis Pharmaceuticals
View Slides

10:25-10:45
Discussion

10:45-11:20
Pharmaceutical Approachs to Antiviral Drug Development
Amy Patick, Ph.D. and Peter Dragovich, Ph.D., Pfizer Inc.
View Slides

11:20-11:30
Discussion

11:30      
BREAK

11:45-12:10
Vaccines: Can we prevent the unexpected?
Alan Shaw, Ph.D., Merck Research Laboratories

12:10-12:30
Discussion

12:30-12:50
SARS: Clearing the Air
Jerome Schentag, Pharm.D., State University of New York-Buffalo
View Slides

12:50-1:00
Discussion

1:00
LUNCH

Session V: Panel Discussion—Preparing for the Next Disease Outbreak
Moderator: Frederick Sparling, M.D., Professor of Medicine, Microbiology, and Immunology, University of North Carolina

2:00        
Discussants:       

The Quest to Define and Control SARS: Robert Breiman, M.D., Cetre for Health and Population Research, Dhaka, Bangladesh
View Slides

Regulatory Laboratory Planning/Preparedness: Kathryn Carbone, M.D., Center for Biologics, Food and Drug Administration
View Slides

Future Threats Assessment: Karen Monaghan, NIC, National Intelligence Council Report

Public Health Law: Gene Matthews, J.D., Legal Advisor to CDC

Modeling a Response Strategy: Nathaniel Hupert, M.D., M.P.H., Weill Cornell Medical College

Face to Face w/ Influenza: Robert Webster, Ph.D., St. Jude Children’s Research Hospital
View Slides

3:30
Open Discussion

5:00
Closing Remarks/ Adjourn

Day 1 Agenda